Search - tctmd.com

Displaying 21 - 40 of 540

Sort: Relevancy | Date

Presentation TCT 2016

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Presenter: William A. Gray, Stephan Windecker

October 31, 2016

Presentation TCT 2016

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani

October 31, 2016

Presentation TCT 2016

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

Presenter: Lutz Buellesfeld, Raj Makkar, Philippe Pibarot

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Presentation TCT 2016

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

Presenter: Maurice Buchbinder, Horst Sievert, Caterina Gandolfo

October 31, 2016

Presentation TCT 2016

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Surgically Implanted Sapien Valve in Mitral Annular Calcium: SITRAL Trial

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

Presentation TCT 2016

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Presenter: Oscar A. Mendiz, Giora Weisz, Caterina Gandolfo

October 30, 2016

News Daily News

开心手术后需要 ICD 和起搏器：系列研究提供了指导

Todd Neale

October 21, 2016

News Daily News

Necesidad de DCI y Marcapasos Post-Cirugía Cardíaca Abierta: Una Serie Ofrece un Punto de Referencia

Todd Neale

October 21, 2016

News Daily News

ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark

Todd Neale

October 21, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Conference News PCR London Valves 2016

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Shelley Wood

September 20, 2016

News Conference News PCR London Valves 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Shelley Wood

September 19, 2016

News Industry News

Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe

September 19, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

Advertisement

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Surgically Implanted Sapien Valve in Mitral Annular Calcium: SITRAL Trial

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

开心手术后需要 ICD 和起搏器：系列研究提供了指导

Necesidad de DCI y Marcapasos Post-Cirugía Cardíaca Abierta: Una Serie Ofrece un Punto de Referencia

ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content